102 related articles for article (PubMed ID: 11400122)
21. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
22. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
23. A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.
Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Mijares V; González-Macías J
Eur J Endocrinol; 2006 Jul; 155(1):53-9. PubMed ID: 16793950
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of estrogen receptor alpha in prostate cancer.
Tanaka Y; Sasaki M; Kaneuchi M; Shiina H; Igawa M; Dahiya R
Mol Carcinog; 2003 Aug; 37(4):202-8. PubMed ID: 12891629
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association.
Försti A; Zhao C; Israelsson E; Dahlman-Wright K; Gustafsson JA; Hemminki K
Breast Cancer Res Treat; 2003 Jun; 79(3):409-13. PubMed ID: 12846425
[TBL] [Abstract][Full Text] [Related]
28. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
29. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
30. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
31. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of the estrogen receptor-alpha gene in familial ovarian cancer.
Wu HJ; Sekine M; Kashima K; Hirai Y; Hatae M; Kobayashi I; Obata K; Enomoto T; Umesaki N; Ushijima K; Tanaka K;
J Obstet Gynaecol Res; 2005 Oct; 31(5):375-83. PubMed ID: 16176503
[TBL] [Abstract][Full Text] [Related]
33. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic repeat in AIB1 does not alter breast cancer risk.
Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Brown M; Hunter DJ
Breast Cancer Res; 2000; 2(5):378-85. PubMed ID: 11056690
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of estrogen receptor alpha gene in endometrial cancer.
Sasaki M; Tanaka Y; Kaneuchi M; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2002 Sep; 297(3):558-64. PubMed ID: 12270131
[TBL] [Abstract][Full Text] [Related]
36. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
37. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.
Paulin FE; O'Neill M; McGregor G; Cassidy A; Ashfield A; Ali CW; Munro AJ; Baker L; Purdie CA; Lane DP; Thompson AM
BMC Cancer; 2008 Oct; 8():281. PubMed ID: 18828900
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
39. Candidate gene approach of familial morbid obesity: linkage analysis of the glucocorticoid receptor gene.
Clément K; Philippi A; Jury C; Pividal R; Hager J; Demenais F; Basdevant A; Guy-Grand B; Froguel P
Int J Obes Relat Metab Disord; 1996 Jun; 20(6):507-12. PubMed ID: 8782725
[TBL] [Abstract][Full Text] [Related]
40. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
